MELTZ MARK A (COO General Counsel Treasurer) reported 1 transaction at KINNATE BIOPHARMA INC.
Review the transaction codes below to understand the nature of each event.
Common Stock
Shares
−27.58K
Price / share
—
Trade value
—
% of position
Net shares
−27.58K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/3/2024 | D · Disposition | −27.58K | — | — | New position | 27.58K | 0.00 |
| Total | −27.58K | $0.00 | ||||||
Stock Option (right to buy)
Common Stock
384.51K shares
Shares
−384.51K
Strike price
2.57
Held after
0.00
Exercisable
—
Stock Option (right to buy)
Common Stock
121.50K shares
Shares
−121.50K
Strike price
5.63
Held after
0.00
Exercisable
—
Stock Option (right to buy)
Common Stock
100K shares
Shares
−100K
Strike price
35.38
Held after
0.00
Exercisable
—
Stock Option (right to buy)
Common Stock
135K shares
Shares
−135K
Strike price
10.03
Held after
0.00
Exercisable
—
Stock Option (right to buy)
Common Stock
215K shares
Shares
−215K
Strike price
6.78
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock384.51K shares | 4/3/2024 | D · Disposition | −384.51K | 2.57 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock121.50K shares | 4/3/2024 | D · Disposition | −121.50K | 5.63 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock100K shares | 4/3/2024 | D · Disposition | −100K | 35.38 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock135K shares | 4/3/2024 | D · Disposition | −135K | 10.03 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock215K shares | 4/3/2024 | D · Disposition | −215K | 6.78 | — | 0.00 |